Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

octreotide pamoate

Known as: OP LAR, Octreotide Embpnate, Octreotide Pamoate LAR(SMS 201-995) 
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
The insulin-like growth factor (IGF)-system was evaluated in 150 breast cancer patients participating in a randomised phase III… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2002
2002
BACKGROUND Long-acting release octreotide pamoate (OP-LAR) is a synthetic octapeptide that can be administered monthly and whose… Expand
Is this relevant?
2002
2002
PURPOSE The purpose of this research was to determine whether insulin-like growth factor (IGF) suppression, using a long-acting… Expand
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
1998
1998
Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment… Expand
  • table 1
  • table 2
Is this relevant?